Selarsdi’s approved presentations include a subcutaneous injection with 45mg/0.5ml and 90mg/ml in a single-dose prefilled syringe ... a proposed biosimilar for Simponi (golimumab) and Simponi ...

Approved presentations of SELARSDI are 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous injection ... a proposed biosimilar for Simponi® (golimumab) and Simponi Aria® ...

Selarsdi’s approved presentations include a subcutaneous injection with 45mg/0.5ml and 90mg/ml in a single-dose prefilled syringe, as well as 45mg/0.5ml ... a proposed biosimilar for Simponi ...

Approved presentations of SELARSDI are 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous ... a proposed biosimilar for Simponi® (golimumab) and Simponi Aria ...

The Global Prefilled Syringes Market is expected to witness a high single-digit growth rate by 2027. The growth of the prefilled syringes market is driven by an increasing prevalence of diverse ...

Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign. The “Treatment MY ...

The expanded interchangeability now applies to the 40mg prefilled syringe and the 40mg and 80mg autoinjectors, in addition to the 20mg and 80mg prefilled syringes. The Food and Drug Administration ...

SMi reports: West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components High-Quality Solutions for Sensitive Molecules, taking place on 16 th July 2020.

Additionally, the recent US approval of Vyvgart Hytrulo as a prefilled syringe for self-injection further enhances patient access and convenience compared with the intravenous infusion of Vyvgart.

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...